Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
Revenue
Valeo Pharma Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Valeo Pharma Inc
TSX:VPH
|
Revenue
CA$53.9m
|
CAGR 3-Years
93%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
|
Bausch Health Companies Inc
TSX:BHC
|
Revenue
$8.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
Theratechnologies Inc
TSX:TH
|
Revenue
$78.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
27%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Revenue
CA$328.2m
|
CAGR 3-Years
18%
|
CAGR 5-Years
92%
|
CAGR 10-Years
N/A
|
Spectral Medical Inc
TSX:EDT
|
Revenue
CA$1.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-5%
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Revenue
$21.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-2%
|
See Also
What is Valeo Pharma Inc's Revenue?
Revenue
53.9m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Revenue amounts to 53.9m CAD.
What is Valeo Pharma Inc's Revenue growth rate?
Revenue CAGR 5Y
65%
Over the last year, the Revenue growth was 94%. The average annual Revenue growth rates for Valeo Pharma Inc have been 93% over the past three years , 65% over the past five years .